2026-10894RuleWallet

FDA Clears Oropharyngeal Zapper Into Class II Medical Devices

Published Date: 6/1/2026

Rule

Summary

The FDA is officially putting the oropharyngeal electrical stimulator into Class II, meaning it has special safety rules but is easier to get to patients. This change helps make sure the device is safe and effective while cutting down on red tape, so more people can benefit from this cool tech. The new rules took effect on June 1, 2026, but the classification has been in place since September 2022.

Analyzed Economic Effects

3 provisions identified: 2 benefits, 1 costs, 0 mixed.

Easier approval path for future devices

FDA's De Novo classification lets this device serve as a predicate so future oropharyngeal electrical stimulators can use the 510(k) process instead of a De Novo or premarket approval, which the FDA says reduces regulatory burden. The De Novo request was received April 19, 2022, and the device was classified on September 16, 2022.

Easier access to swallowing device

The FDA classified the oropharyngeal electrical stimulator as Class II with special controls, which the agency says will enhance patients' access to the device and reduce regulatory burdens. The final order is effective June 1, 2026, and the classification was applicable on September 16, 2022.

New testing, labeling, and 510(k) duties

To fall within Class II, oropharyngeal electrical stimulators must meet special controls such as non-clinical performance testing (electrical output, mechanical integrity, oxygen safety), biocompatibility, sterility and shelf-life testing, reprocessing validation, software verification and hazard analysis, electromagnetic compatibility, training programs, usability testing, and labeling that includes shelf life. FDA also states the device is subject to premarket notification under section 510(k).

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Rule Effective
6/1/2026
6/1/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register